Brixo
Skip to main content
Back to Healthcare Agents
Abridge logo

Abridge

Abridge was founded in 2018 with the mission of powering deeper understanding in healthcare. Our Best in KLAS AI-powered platform was purpose-built for medical conversations, improving clinical documentation efficiencies while enabling clinicians to focus on what matters most—their patients. Our enterprise-grade technology transforms patient-clinician conversations into structured clinical notes in real-time, with deep EMR integrations. Powered by Linked Evidence and our purpose-built, auditable AI, we are the only company that maps AI-generated summaries to ground truth, helping providers quickly trust and verify the output. As pioneers in generative AI for healthcare, we are setting the industry standards for the responsible deployment of AI across health systems.

Visit Website

Founded

2018

Location

San Francisco, CA

Employees

444

Funding

$300M Series E

Abridge: Enterprise Ambient AI for Healthcare Documentation

Overview

Abridge delivers enterprise‑grade ambient AI that listens to patient‑clinician conversations and drafts structured, billable notes in real time. Every line of the draft is anchored to “linked evidence” from the original audio/transcript so clinicians can verify quickly, maintain revenue integrity, and stay in workflow—especially within Epic. Founded in 2018 by cardiologist Shiv Rao, Abridge has scaled through tight EHR integrations and large health system deployments, with live documentation of its rollout at [Johns Hopkins IT](https://it.johnshopkins.edu/ai/abridge-ai-scribe/).

  • Core value: **Less time charting, more time with patients**, without leaving the EHR.
  • Differentiator: **Linked evidence** ties draft content to source audio/transcript to support trust, auditability, and compliance.
  • Revenue focus: **Coding‑aware note generation** aligns language to appropriate billing codes.
  • Learn more at the [Abridge website](https://www.abridge.com/) and product pages for [Ambient AI Scribe](https://www.abridge.com/product) and [AI approach](https://www.abridge.com/ai).

    Key Capabilities

  • Real‑time ambient capture of clinical encounters with in‑workflow EHR review
  • Structured, coding‑aware notes designed to support revenue integrity
  • “Linked evidence” view mapping each note element to source audio/transcript
  • Drafting of after‑visit summaries from the same encounter audio
  • Emerging pilots beyond note generation (e.g., assisting prior authorization during visits)
  • Emphasis on enterprise readiness, auditability, and **responsible AI**
  • Sources: [Product overview](https://www.abridge.com/), [Product details](https://www.abridge.com/product), [AI approach](https://www.abridge.com/ai).

    Integrations and Workflow

  • Epic: In‑workflow review and note insertion; Abridge was announced as Epic’s first PAL partner, expanding access via Epic’s ecosystem. See the [Epic PAL announcement](https://www.abridge.com/press-release/abridge-becomes-epics-first-pal-bringing-generative-ai-to-more-providers-and-patients).
  • Live health‑system deployment documentation: [Johns Hopkins IT page](https://it.johnshopkins.edu/ai/abridge-ai-scribe/), describing ambient capture and transcript‑based note review in the EHR.
  • Other EHRs: Additional integrations are referenced in media, but Epic is the most visible and documented publicly.
  • Who It’s For

  • Health systems and large medical groups standardizing documentation across service lines
  • Clinicians in ambulatory and inpatient settings seeking to reduce after‑hours charting
  • Informatics, coding, and revenue integrity teams needing auditable, coding‑aware drafts
  • Common Use Cases

  • Ambient documentation of office visits and inpatient encounters
  • Fast “trust‑and‑verify” note review using linked evidence inside the EHR
  • Coding‑aware note generation aligned to billing language
  • Drafting patient after‑visit summaries from encounter audio
  • Pilots for **real‑time prior authorization** support during visits
  • Proof Points and Recognition

  • Industry recognition: Abridge earned a triple top‑five ranking in KLAS Emerging Solutions, including **No. 1 for clinician experience (2024)**. See the [BusinessWire summary](https://www.businesswire.com/news/home/20241022492850/en/Abridge-Becomes-First-Ever-Generative-AI-Company-to-Earn-Triple-Top-Five-Ranking-in-KLAS-Emerging-Solutions-Report-Including-No.-1-for-Clinician-Experience) and the [KLAS vendor page](https://klasresearch.com/vendor-ratings/abridge/97880).
  • Deployed at leading systems: Public documentation of the operational workflow at [Johns Hopkins IT](https://it.johnshopkins.edu/ai/abridge-ai-scribe/).
  • Strong Epic workflow fit: Clinician discussions note ease of use in live practice; see user sentiment on [Reddit](https://www.reddit.com/r/FamilyMedicine/comments/1ggmdf8/thoughtsexperiences_working_with_ai_scribes/).
  • Market Context

    As Epic expands native AI scribing capabilities, competitive dynamics are shifting. Abridge emphasizes its **Epic integrations**, enterprise readiness, **auditability**, and measurable outcomes to differentiate. For analysis of Epic’s strategy, see [Fierce Healthcare coverage](https://www.fiercehealthcare.com/ai-and-machine-learning/how-epics-ai-moves-could-shake-health-tech-market), and broader relationship reporting in [Business Insider](https://www.businessinsider.com/inside-messiest-relationship-in-healthcare-ai-abridge-epic-2025-9).

    Funding and Growth

  • Series C: Abridge announced a **$150M Series C** in late 2024; see the [press release](https://www.abridge.com/press-release/series-c-150).
  • Continued expansion: Reporting in 2025 highlights new inpatient modules and additional funding activity; see coverage via [2 Minute Medicine](https://www.2minutemedicine.com/abridge-drafts-pediatric-notes-so-physicians-stay-with-the-kids-not-the-keyboard/).
  • Benefits (User Sentiment)

  • Reduces documentation time and after‑hours charting; corroborated by multiple clinician reports and health‑system IT pages like [Johns Hopkins IT](https://it.johnshopkins.edu/ai/abridge-ai-scribe/).
  • High marks for clinician experience in third‑party evaluations: [KLAS recognition summary](https://www.businesswire.com/news/home/20241022492850/en/Abridge-Becomes-First-Ever-Generative-AI-Company-to-Earn-Triple-Top-Five-Ranking-in-KLAS-Emerging-Solutions-Report-Including-No.-1-for-Clinician-Experience).
  • Strong Epic workflow fit noted in clinician discussion threads on [Reddit](https://www.reddit.com/r/FamilyMedicine/comments/1ggmdf8/thoughtsexperiences_working_with_ai_scribes/).
  • Considerations and Caveats

  • Accuracy requires clinician review; performance can vary by specialty and encounter type. See user discussion on [Reddit](https://www.reddit.com/r/FamilyMedicine/comments/1ggmdf8/thoughtsexperiences_working_with_ai_scribes/).
  • Ongoing questions about long‑term data handling and regulatory posture for ambient AI scribes; review commentary such as this [Substack post](https://sergeiai.substack.com/p/mayo-clinic-abridge-not-fda-approved) and verify with your compliance team.
  • Vendor lock‑in and market noise as Epic advances native features; see [Business Insider analysis](https://www.businessinsider.com/inside-messiest-relationship-in-healthcare-ai-abridge-epic-2025-9).
  • Pricing, Sales Motion, and Trial

  • Public pricing is not listed; procurement appears enterprise and sales‑led.
  • No standardized public free trial disclosed.
  • Explore offerings on the [Abridge product site](https://www.abridge.com/product) and [company homepage](https://www.abridge.com/).
  • Company Snapshot

  • Company: Abridge
  • Founded: 2018
  • Leadership: CEO **Shiv Rao**; COO **Julia Chou**; technology leadership with ML expertise from CMU
  • HQ: Pittsburgh‑area roots; [LinkedIn lists HQ as San Francisco, CA](https://www.linkedin.com/company/abridgehq)
  • Employees: ~446 (LinkedIn)
  • Product: **Ambient AI scribe** with linked evidence and coding‑aware note generation
  • Notable integrations: **Epic**, including [PAL announcement](https://www.abridge.com/press-release/abridge-becomes-epics-first-pal-bringing-generative-ai-to-more-providers-and-patients); live deployment at [Johns Hopkins IT](https://it.johnshopkins.edu/ai/abridge-ai-scribe/)
  • Recognition: Triple top‑five in KLAS Emerging Solutions; **No. 1 for clinician experience (2024)** — [BusinessWire](https://www.businesswire.com/news/home/20241022492850/en/Abridge-Becomes-First-Ever-Generative-AI-Company-to-Earn-Triple-Top-Five-Ranking-in-KLAS-Emerging-Solutions-Report-Including-No.-1-for-Clinician-Experience)
  • Funding: [Series C $150M (2024)](https://www.abridge.com/press-release/series-c-150); additional 2025 growth reporting on inpatient modules and funding via [2 Minute Medicine](https://www.2minutemedicine.com/abridge-drafts-pediatric-notes-so-physicians-stay-with-the-kids-not-the-keyboard/)
  • Related Reading

  • Company and product: [Abridge homepage](https://www.abridge.com/), [Product](https://www.abridge.com/product), [AI approach](https://www.abridge.com/ai)
  • Recognition: [BusinessWire KLAS summary](https://www.businesswire.com/news/home/20241022492850/en/Abridge-Becomes-First-Ever-Generative-AI-Company-to-Earn-Triple-Top-Five-Ranking-in-KLAS-Emerging-Solutions-Report-Including-No.-1-for-Clinician-Experience), [KLAS vendor page](https://klasresearch.com/vendor-ratings/abridge/97880)
  • Epic relationship and market: [Epic PAL announcement](https://www.abridge.com/press-release/abridge-becomes-epics-first-pal-bringing-generative-ai-to-more-providers-and-patients), [Fierce Healthcare analysis](https://www.fiercehealthcare.com/ai-and-machine-learning/how-epics-ai-moves-could-shake-health-tech-market), [Business Insider](https://www.businessinsider.com/inside-messiest-relationship-in-healthcare-ai-abridge-epic-2025-9)
  • Live deployment: [Johns Hopkins IT](https://it.johnshopkins.edu/ai/abridge-ai-scribe/)
  • Tip: For compliance teams, review Abridge’s linked‑evidence workflows and your organization’s policies on ambient audio capture, data retention, and intended use before deployment.

    Related Companies

    Ambience Healthcare logo

    Ambience Healthcare

    Ambience Healthcare is the leading AI platform for documentation, coding, and clinical workflows, built to reduce administrative burden and protect revenue integrity at the point of care. Trusted by top health systems across North America, Ambience’s platform is live across outpatient, emergency, and inpatient settings, supporting more than 100 specialties with real-time, coding-aware documentation. The platform integrates directly with Epic, Oracle Cerner, athenahealth, and other major EHRs. Founded in 2020 by Mike Ng and Nikhil Buduma, Ambience is headquartered in San Francisco and backed by Oak HC/FT, Andreessen Horowitz (a16z), OpenAI Startup Fund, Kleiner Perkins, and other leading investors. For official information or questions on available roles, please visit https://careers.ambiencehealthcare.com

    Corti logo

    Corti

    Corti offers the worlds most powerful AI models for healthcare, directly available through our API.

    Hippocratic AI logo

    Hippocratic AI

    Nabla logo

    Nabla

    Nabla is on a mission to restore the human connection at the heart of healthcare through industry-leading clinical AI that optimizes clinical and financial workflows. Our AI assistant helps clinicians generate high-quality notes in seconds and streamline multiple workflows through ambient documentation, dictation, and real-time coding support. Nabla integrates with all major EHRs, supports more than 35 languages, and is used across over 130 health systems and provider groups. Nabla is building the most advanced agentic AI assistant for clinicians, evolving into an Adaptive Agentic Platform: a smarter assistant that helps with coding, proactive EHR actions, and can support across new care settings and clinical roles. Nabla was founded by Alex LeBrun (CEO), Delphine Groll (COO), and Martin Raison (CTO). Its leadership includes Dr. Ed Lee, Chief Medical Officer and former CIO of The Permanente Federation. Nabla’s advisors include Yann LeCun (Meta) and Tony Fadell (Build Collective). The company has raised $120 million from HV Capital, Highland Europe, Cathay Innovation, and others.

    OpenEvidence logo

    OpenEvidence